List of Tables
Summary Table A: Global Market for Organ and Tissue Transplantation and Alternatives, by Product & Devices, Through 2024
Summary Table B: Global Market for Organ and Tissue Transplantation and Alternatives, by Region, Through 2024
Table 1: MiMedx: Patent Portfolio
Table 2: Product Launches in Transplant Diagnostics, 2012-2016
Table 3: Global Market for Organ and Tissue Transplantation and Alternatives, by Product & Devices, Through 2024
Table 4: Global Market for Alternative Technologies in Organ and Tissue Transplantation and Alternatives, Through 2024
Table 5: Selected Global Commercial Opportunities for New Orthopedic Devices in the Future
Table 6: Indications for Bioartificial Liver Transplantation
Table 7: Global Market for Alternative Technologies in the Organ and Tissue Transplantation and Alternatives Market, by Region, Through 2024
Table 8: Global Market for Tissue Products in the Organ and Tissue Transplantation and Alternatives Market, Through 2024
Table 9: Cartilage and Soft Tissue Biologics and Biomaterials
Table 10: Global Market of Tissue Products in Organ and Tissue Transplantation and Alternatives, by Region, Through 2024
Table 11: Therapeutic Effects of Immunosuppressants
Table 12: Global Market for Immunosuppressants in the Organ and Tissue Transplantation and Alternatives Market, Through 2024
Table 13: Immunosuppressants, by Drug Class, Generic Name, Brand Name, and Manufacturer
Table 14: Global Market of Immunosuppressants in the Organ and Tissue Transplantation and Alternatives, by Region, Through 2024
Table 15: Cold Ischemia Time for Transplanted Organs
Table 16: Global Market for Solid Organ Preservation Solutions in Organ and Tissue Transplantation and Alternatives, Through 2024
Table 17: Optimal Preservation Solution Design
Table 18: Major Organ Preservation Solutions
Table 19: Global Market for Solid Organ Preservation Solutions in Organ and Tissue Transplantation and Alternatives, by Region, Through 2024
Table 20: Tissue Typing Technologies
Table 21: Global Market for Tissue Typing in Organ and Tissue Transplantation and Alternatives, Through 2024
Table 22: Global Market for Tissue Typing in Organ and Tissue Transplantation and Alternatives, by Region, Through 2024
Table 23: Global Market for Organ and Tissue Transplantation and Alternatives, by Region, Through 2024
Table 24: North American Market for Organ and Tissue Transplantation and Alternatives, by Product & Devices, Through 2024
Table 25: North American Market for Organ and Tissue Transplantation and Alternatives, by Country, Through 2024
Table 26: European Market for Organ and Tissue Transplantation and Alternatives, by Product & Devices, Through 2024
Table 27: European Market for Organ and Tissue Transplantation and Alternatives, by Country, Through 2024
Table 28: Transplant Numbers in Germany, 2013-2019
Table 29: Statistics for Cost of Bone Damage Repair and Related Disorders in Europe
Table 30: Asia-Pacific Market for Organ and Tissue Transplantation and Alternatives, by Product & Devices, Through 2024
Table 31: Asia-Pacific Market for Organ and Tissue Transplantation and Alternatives, by Country, Through 2024
Table 32: Types of Organ Rejection After Transplant Procedures
Table 33: Organ Transplantation Rates in Southeast Asian Countries, 2011-2014
Table 34: Rest of the World Market for Organ and Tissue Transplantation and Alternatives, by Product & Devices, Through 2024
Table 35: Registered Liver Transplantations (LT)/Kidney Transplantation in Middle East Countries, 2017
Table 36: Rest of the World Market for Organ and Tissue Transplantation and Alternatives, by Country, Through 2024
Table 37: Communicable and Noncommunicable Diseases Leading to Mortality in Brazil, 2018
Table 38: Number of Organ Transplant Procedures in Brazil, by Type of Organ, 2015
Table 39: Number of Organ Transplant Procedures in Turkey, by Type of Organ, 2019-2020
Table 40: Pharmaceutical Company Efforts to Tackle COVID-19
Table 41: U.S. Organ/Tissue Transplants: Total Estimated Transplants and Estimated Billed Charges, 2019
Table 42: Immunosuppressive Drugs Currently Covered, by Medicare*
Table 43: Overview of Medicare Immunosuppressive Drug Coverage
Table 44: Selected Transplant Industry Acquisitions, 2010-Early 2015
Table 45: Abiomed Inc: Product Portfolio
Table 46: AbbVie: Product Portfolio
Table 47: Amgen Inc.: Product Portfolio
Table 48: AstraZeneca: Product Portfolio
Table 49: Bayer AG: Product Portfolio
Table 50: Bristol-Myers Squibb: Product Portfolio
Table 51: CareDx Inc.: Product Portfolio
Table 52: F. Hoffmann-La Roche & Co.: Product Portfolio
Table 53: Johnson & Johnson: Immunosuppressants Product Portfolio
Table 54: Mylan N.V.: Product Portfolio
Table 55: Novartis AG: Product Portfolio
Table 56: Pfizer Inc.: Product Portfolio
Table 57: Pfizer Inc.: Pipeline Product Portfolio
Table 58: Transmedics Inc.: Product Portfolio
Table 59: Vertex Pharmaceuticals Inc.: Product Portfolio
Table 60: XVIVO Perfusion: Product Portfolio
Table 61: Acronyms Used in This Report
List of Figures
Summary Figure A: Global Market for Organ and Tissue Transplantation and Alternatives, by Product & Devices, 2018-2024
Summary Figure B: Global Market Shares of Organ and Tissue Transplantation and Alternatives, by Alternative Technologies, 2019
Summary Figure C: Global Market Shares for Organ and Tissue Transplantation and Alternatives, by Tissue Products, 2019
Summary Figure D: Global Market Shares for Organ and Tissue Transplantation and Alternatives, by Immunosuppressants, 2019
Summary Figure E: Global Market Shares for Organ and Tissue Transplantation and Alternatives, by Solid Organ Preservation Solutions, 2019
Figure 1: Nanotechnology and Tissue Regeneration
Figure 2: Number of Elderly (= 65 Years) Receiving Kidney Transplantation in the U.S., 2014-2018
Figure 3: Number of Diabetes Patients Globally (20 to 79 Years of Age), 2000-2045
Figure 4: Waiting List for Organs in the U.S., by Type of Organ, September 2020
Figure 5: Number of Kidney Transplants, by Country, 2015
Figure 6: Patients on Waiting List vs. Transplant Performed in the U.S., by Organ, 2019
Figure 7: Global Market Shares of Organ and Tissue Transplantation and Alternatives, by Product & Devices, 2019
Figure 8: Global Market for Alternative Technologies in Organ and Tissue Transplantation and Alternatives, 2018-2024
Figure 9: Global Market Shares of Alternative Technologies in Organ and Tissue Transplantation and Alternatives, 2019
Figure 10: Global Market Shares of Orthopedic Alternatives in Organ and Tissue Transplantation and Alternatives, 2019
Figure 11: Global Market for Alternative Technologies in the Organ and Tissue Transplantation and Alternatives Market, by Region, 2018-2024
Figure 12: Global Market for Tissue Products in the Organ and Tissue Transplantation and Alternatives Market, 2018-2024
Figure 13: Global Market Shares for Tissue Products in the Organ and Tissue Transplantation and Alternatives Market, 2019
Figure 14: Global Market Shares for Peripheral Blood Stem Cells, Cord Blood, Bone Marrow in the Organ and Tissue Transplantation and Alternatives Market, 2019
Figure 15: Global Market Shares for Orthobiologics (Bone Allografts, Machined Bone, DBM) in the Organ and Tissue Transplantation and Alternatives Market, 2019
Figure 16: Global Market of Tissue Products in Organ and Tissue Transplantation and Alternatives, by Region, 2018-2024
Figure 17: Global Market for Immunosuppressants in the Organ and Tissue Transplantation and Alternatives, 2018-2024
Figure 18: Global Market Shares for Immunosuppressants in the Organ and Tissue Transplantation and Alternatives Market, 2019
Figure 19: Global Market Shares for Calcineurin Inhibitors in the Organ and Tissue Transplantation and Alternatives Market, 2019
Figure 20: Global Market Shares for Anti-proliferative Agents in the Organ and Tissue Transplantation and Alternatives Market, 2019
Figure 21: Global Market Shares for m-TOR Inhibitors in the Organ and Tissue Transplantation and Alternatives Market, 2019
Figure 22: Global Market Shares for Polyclonal Antibodies in the Organ and Tissue Transplantation and Alternatives Market, 2019
Figure 23: Global Market of Immunosuppressants in Organ and Tissue Transplantation and Alternatives, by Region, 2018-2024
Figure 24: Global Market for Solid Organ Preservation Solutions in Organ and Tissue Transplantation and Alternatives, 2018-2024
Figure 25: Global Market Shares for Solid Organ Preservation Solutions in Organ and Tissue Transplantation and Alternatives, 2019
Figure 26: Global Market for Solid Organ Preservation Solutions in Organ and Tissue Transplantation and Alternatives, by Region, 2018-2024
Figure 27: Global Market for Tissue Typing in Organ and Tissue Transplantation and Alternatives, 2018-2024
Figure 28: Global Market for Tissue Typing in Organ and Tissue Transplantation and Alternatives, by Region, 2018-2024
Figure 29: Global Market Shares of Organ and Tissue Transplantation and Alternatives, by Region, 2019
Figure 30: North American Market Shares of Organ and Tissue Transplantation and Alternatives, by Product & Devices, 2019
Figure 31: North American Market Shares of Organ and Tissue Transplantation and Alternatives, by Alternative Devices, 2019
Figure 32: North American Market Shares of Organ and Tissue Transplantation and Alternatives, by Tissue Products, 2019
Figure 33: North American Market Shares of Organ and Tissue Transplantation and Alternatives, by Immunosuppressants, 2019
Figure 34: North American Market Shares of Organ and Tissue Transplantation and Alternatives, by Solid Organ Preservation Solutions, 2019
Figure 35: North American Market Shares for Organ and Tissue Transplantation and Alternatives, by Country, 2019
Figure 36: United States Market for Organ and Tissue Transplantation and Alternatives, 2018-2024
Figure 37: Canadian Market for Organ and Tissue Transplantation and Alternatives, 2018-2024
Figure 38: Mexican Market for Organ and Tissue Transplantation and Alternatives, 2018-2024
Figure 39: European Market Shares of Organ and Tissue Transplantation and Alternatives, by Product & Devices, 2019
Figure 40: European Market Shares of Organ and Tissue Transplantation and Alternatives, by Alternative Technologies, 2019
Figure 41: European Market Shares of Organ and Tissue Transplantation and Alternatives, by Tissue Products, 2019
Figure 42: European Market Shares of Organ and Tissue Transplantation and Alternatives, by Immunosuppressants, 2019
Figure 43: European Market Shares of Organ and Tissue Transplantation and Alternatives, by Solid Organ Preservation Solutions, 2019
Figure 44: European Market Shares of Organ and Tissue Transplantation and Alternatives, by Country, 2019
Figure 45: German Market for Organ and Tissue Transplantation and Alternatives, 2018-2024
Figure 46: French Market for Organ and Tissue Transplantation and Alternatives, 2018-2024
Figure 47: U.K. Market for Organ and Tissue Transplantation and Alternatives, 2018-2024
Figure 48: Italian Market for Organ and Tissue Transplantation and Alternatives, 2018-2024
Figure 49: Spanish Market for Organ and Tissue Transplantation and Alternatives, 2018-2024
Figure 50: Rest of Europe Market for Organ and Tissue Transplantation and Alternatives, 2018-2024
Figure 51: Asia-Pacific Market Shares of Organ and Tissue Transplantation and Alternatives, by Product & Devices, 2019
Figure 52: Asia-Pacific Market Shares of Organ and Tissue Transplantation and Alternatives, by Alternative Technologies, 2019
Figure 53: Asia-Pacific Market Shares of Organ and Tissue Transplantation and Alternatives, by Tissue Products, 2019
Figure 54: Asia-Pacific Market Shares of Organ and Tissue Transplantation and Alternatives, by Immunosuppressants, 2019
Figure 55: Asia-Pacific Market Shares of Organ and Tissue Transplantation and Alternatives, by Solid Organ Preservation Solutions, 2019
Figure 56: Asia-Pacific Market Shares of Organ and Tissue Transplantation and Alternatives, by Country, 2019
Figure 57: Japanese Market for Organ and Tissue Transplantation and Alternatives, 2018-2024
Figure 58: Chinese Market for Organ and Tissue Transplantation and Alternatives, 2018-2024
Figure 59: Indian Market for Organ and Tissue Transplantation and Alternatives, 2018-2024
Figure 60: Australia and New Zealand’s Market for Organ and Tissue Transplantation and Alternatives, 2018-2024
Figure 61: Number of Organ Donations in Australia, by Type of Donor, 2015
Figure 62: Rest of Asia-Pacific Market for Organ and Tissue Transplantation and Alternatives, 2018-2024
Figure 63: Rest of the World Market Shares of Organ and Tissue Transplantation and Alternatives, by Products & Devices, 2019
Figure 64: Rest of the World Market Shares of Organ and Tissue Transplantation and Alternatives, by Alternative Technologies, 2019
Figure 65: Rest of the World Market Shares of Organ and Tissue Transplantation and Alternatives, by Tissue Products, 2019
Figure 66: Rest of the World Market Shares of Organ and Tissue Transplantation and Alternatives, by Immunosuppressants, 2019
Figure 67: Rest of the World Market Shares of Organ and Tissue Transplantation and Alternatives, by Solid Organ Preservation Solutions, 2019
Figure 68: Rest of the World Market Shares of Organ and Tissue Transplantation and Alternatives, by Country, 2019
Figure 69: Brazilian Market for Organ and Tissue Transplantation and Alternatives, 2018-2024
Figure 70: South African Market for Organ and Tissue Transplantation and Alternatives, 2018-2024
Figure 71: Rest of the World Countries Market for Organ and Tissue Transplantation and Alternatives, 2018-2024
Figure 72: Steep Reduction in Organ Transplantation Seen During COVID-19
Figure 73: Global Market Ranking in the Organ and Tissue Transplantation and Alternatives Market, by Pharmaceutical Company, 2019
Figure 74: Global Market Ranking of Organ and Tissue Transplantation and Alternatives, by Diagnostic and Alternatives in the Organ Manufacturing Industry, 2019
Figure 75: Abiomed Inc.: Annual Revenue, 2016-2020
Figure 76: Abiomed Inc.: Revenue Shares for R&D, by Impella Devices, 2016-2020
Figure 77: AbbVie: Annual Revenue, 2016-2019
Figure 78: AbbVie: Revenue Shares, by Region/Country, 2019
Figure 79: AbbVie: Revenue Shares, by Business Unit, 2019
Figure 80: Amgen Inc.: Annual Revenue, 2016-2019
Figure 81: Amgen Inc.: Revenue Shares, by Region/Country, 2019
Figure 82: Amgen Inc.: Revenue Shares, by Products, 2019
Figure 83: AstraZeneca: Annual Revenue, 2016-2019
Figure 84: AstraZeneca: Revenue Shares, by Region/Country, 2019
Figure 85: AstraZeneca: Revenue Shares, by Business Unit, 2019
Figure 86: Bayer AG: Annual Revenue, 2016-2019
Figure 87: Bayer AG: Revenue Shares, by Region, 2019
Figure 88: Bayer AG: Revenue Shares, by Business Unit, 2019
Figure 89: Bristol-Myers Squibb: Annual Revenue, 2016-2019
Figure 90: Bristol-Myers Squibb: Revenue Shares, by Region/Country, 2019
Figure 91: Bristol-Myers Squibb: Revenue Shares, by Brands, 2019
Figure 92: CareDx Inc.: Annual Revenue, 2016-2019
Figure 93: CareDx Inc.: Revenue Shares in Pharmaceutical Segment, by Region/Country, 2019
Figure 94: CareDx Inc.: Revenue Shares, by Business Segment, 2019
Figure 95: F. Hoffmann-La Roche & Co.: Annual Revenue, 2016-2019
Figure 96: F. Hoffmann-La Roche & Co.: Revenue Shares in Pharmaceutical Segment, by Region/Country, 2019
Figure 97: F. Hoffmann-La Roche & Co.: Revenue Shares, by Business Segment, 2019
Figure 98: Johnson & Johnson: Annual Revenue, 2016-2019
Figure 99: Johnson & Johnson: Revenue Shares, by Region/Country, 2019
Figure 100: Johnson & Johnson: Revenue Shares, by Business Unit, 2019
Figure 101: Mylan N.V.: Annual Revenue, 2016-2019
Figure 102: Mylan N.V.: Revenue Shares, by Region, 2019
Figure 103: Mylan N.V.: Revenue Shares, by Business Unit, 2019
Figure 104: Novartis AG.: Annual Revenue, 2015-2019
Figure 105: Novartis AG: Revenue Shares, by Region/Country, 2019
Figure 106: Novartis AG: Revenue Shares, by Business Segment, 2019
Figure 107: Pfizer Inc.: Annual Revenue, 2016-2019
Figure 108: Pfizer Inc.: Revenue Shares, by Region/Country, 2019
Figure 109: Pfizer Inc.: Revenue Shares, by Business Segment, 2019
Figure 110: Transmedics Inc.: Annual Revenue, 2018 and 2019
Figure 111: Transmedics Inc.: Revenue Shares, by OCS Product, 2019
Figure 112: Transmedics Inc.: Revenue Shares, by Region/Country, 2019
Figure 113: Vertex Pharmaceuticals Inc.: Annual Revenue, 2016-2019
Figure 114: Vertex Pharmaceuticals Inc.: Research and Development Expense, 2017-2019
Figure 115: Vertex Pharmaceuticals Inc.: Revenue Shares, by Business Segment, 2019
Figure 116: XVIVO Perfusion: Annual Revenue, 2018 and 2019
Figure 117: XVIVO Perfusion: Revenue Shares, by Region, 2019